BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 17451498)

  • 1. Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia.
    van den Berg I; Pijpe J; Vissink A
    Eur J Oral Sci; 2007 Apr; 115(2):97-102. PubMed ID: 17451498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
    Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
    Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
    Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
    J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Salivary factors in Gougerot-Sjogren's syndrome].
    Cernéa P; Laudenbach P; Szabo G; Hosxe G; Boumaza M
    Rev Stomatol Chir Maxillofac; 1972 Nov; 73(7):529-41. PubMed ID: 4513260
    [No Abstract]   [Full Text] [Related]  

  • 5. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome.
    Kalk WW; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Nieuw Amerongen AV
    Ann Rheum Dis; 2001 Dec; 60(12):1110-6. PubMed ID: 11709452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome.
    Kalk WW; Vissink A; Stegenga B; Bootsma H; Nieuw Amerongen AV; Kallenberg CG
    Ann Rheum Dis; 2002 Feb; 61(2):137-44. PubMed ID: 11796400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of diseases of the salivary glands.
    Hall HD
    J Oral Surg; 1969 Jan; 27(1):15-25. PubMed ID: 5248070
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral parameters in the diagnosis of Sjögren's syndrome.
    Scully C
    Clin Exp Rheumatol; 1989; 7(2):113-7. PubMed ID: 2661071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for the salivary component of Sjögren's syndrome. A review.
    Schiødt M; Thorn J
    Clin Exp Rheumatol; 1989; 7(2):119-22. PubMed ID: 2661072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialendoscopy of Salivary Glands Affected by Sjögren Syndrome: A Randomized Controlled Pilot Study.
    Jager DJ; Karagozoglu KH; Maarse F; Brand HS; Forouzanfar T
    J Oral Maxillofac Surg; 2016 Jun; 74(6):1167-74. PubMed ID: 26850868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation.
    Mansour MJ; He C; Al-Farra ST; Khuder SA; Wright JM; Kessler HP; Hinton RJ; Al-Hashimi I
    J Oral Pathol Med; 2013 Sep; 42(8):594-9. PubMed ID: 23480241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of xerostomia by quantitative salivary gland scintigraphy.
    Häusler RJ; Ritschard J; N'Guyen VT; Montandon PB
    Ann Otol Rhinol Laryngol; 1977; 86(3 Pt 1):333-41. PubMed ID: 869435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment and diagnosis of immunologically mediated salivary gland disease in Sjögren's syndrome.
    Daniels TE
    J Autoimmun; 1989 Aug; 2(4):529-41. PubMed ID: 2789655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stomatological manifestations in Sjögren's disease and syndrome].
    Simonova MV; Gritsman NN; Venikova MS; Mylov NM
    Ter Arkh; 1988; 60(4):32-4. PubMed ID: 3394093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of furosemide and bendroflumethiazide on saliva flow rate and composition.
    Nederfors T; Nauntofte B; Twetman S
    Arch Oral Biol; 2004 Jul; 49(7):507-13. PubMed ID: 15126132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
    Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
    Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing diagnostic criteria for the salivary component of Sjögren's syndrome.
    Schiødt M; Daniels TE; Greenspan JS; Oxholm P; Prause JU; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():44-6. PubMed ID: 3473648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
    Yamada H; Nakagawa Y; Wakamatsu E; Sumida T; Yamachika S; Nomura Y; Mishima K; Saito I
    Clin Rheumatol; 2007 Aug; 26(8):1320-7. PubMed ID: 17221146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome.
    Simmons DD; Al-Hashimi I; Haghighat N
    Quintessence Int; 2000 Mar; 31(3):196-200. PubMed ID: 11203926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.